Sondra Pfeiffer is a notable inventor based in Kernersville, NC (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various medical conditions. With a total of 2 patents to her name, her work has the potential to impact the treatment of disorders related to the central and autonomic nervous systems.

Latest Patents

Pfeiffer's latest patents include innovative compounds such as (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide and its novel salt forms. These inventions focus on methods for their preparation and the treatment of a wide variety of conditions and disorders. The compounds are designed to address dysfunctions within the central and autonomic nervous systems, showcasing her commitment to advancing medical science.

Career Highlights

Sondra Pfeiffer is currently employed at Targacept, Inc., where she continues to innovate and develop new pharmaceutical solutions. Her work at Targacept has positioned her as a key player in the field, contributing to the company's mission of creating effective treatments for complex medical issues.

Collaborations

Throughout her career, Pfeiffer has collaborated with talented professionals, including Merouane Bencherif and Lisa Benson. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Sondra Pfeiffer's contributions to pharmaceutical chemistry through her patents and work at Targacept, Inc. highlight her role as an influential inventor. Her innovative approaches to treating medical conditions demonstrate the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.